Showing 451-460 of 1697 results for "".
FDA Filing for Cannabidiol, Data on Diet and Exercise and Brain Aging and Memory, Boston Scientific Indication for DBS
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/fda-filing-for-cannabidiol-data-on-diet-and-excercise-and-brain-aging-and-memory-boston-scientific-indication-for-dbs/30285/Telepresence in Neurology
https://practicalneurology.com/columns/practice-management/telepresence-in-neurology/30389/Neurologists' Experiences with EHRs: The Texas Perspective
https://practicalneurology.com/columns/practice-management/neurologists-experiences-with-ehrs-the-texas-perspective/30779/The Texas Neurological Society surveyed its membership about their experiences with EHRs. Results show generally moderate to low satisfaction.Therapeutics Q&A:
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/therapeutics-qa/30861/The first drug approved specifically to manage a symptom of MS is shown to improve patients' walking ability.Action Tremor and Gait Imbalance With Eventual Cognitive Decline
https://practicalneurology.com/diseases-diagnoses/movement-disorders/action-tremor-and-gait-imbalance-with-eventual-cognitive-decline-video/30249/Short Takes
https://practicalneurology.com/columns/practice-management/PN0109_08-php/30960/Seizure Detection and SUDEP Prevention
https://practicalneurology.com/diseases-diagnoses/child-neurology/seizure-detection-and-sudep-prevention/30160/Seizure detection and alerting devices hold promise for preventing sudden death in epilepsy.Health Law Update: What's Next?
https://practicalneurology.com/columns/practice-management/health-law-update-whats-next/30687/The Independent Payment Advisory Board was tasked with achieving savings in Medicare but has now been gutted by Congress and may never become operational.Expert Opinion
https://practicalneurology.com/columns/practice-management/expert-opinion/30765/Spinal Injury from Electrocautery ShockRaising Urate With Inosine to Potentially Slow Progression of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-focus/30688/Results of the Phase II SURE-PD study show inosine is safe and tolerable and raises urate levels, which have been inversely related to Parkinson's progression. Still, patients are cautioned against self-medicating before the next phase of this research effort is completed.